BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35978363)

  • 1. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P
    World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.
    Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
    Clin Transl Oncol; 2023 Aug; 25(8):2462-2471. PubMed ID: 37093455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer].
    Wei YL; Cui YH; Dong YH; Shi WJ
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
    De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H
    Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The largest lymph node defined response to neoadjuvant chemotherapy can predict long-term prognosis in locally advanced gastric cancer.
    Liu L; Wang Y; Liu T; Rao S; Zeng M
    Abdom Radiol (NY); 2023 Dec; 48(12):3653-3660. PubMed ID: 37755476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis.
    Ergenç M; Uprak TK; Akın Mİ; Hekimoğlu EE; Çelikel ÇA; Yeğen C
    BMC Surg; 2023 Aug; 23(1):220. PubMed ID: 37550669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Lymph Node Ratio in Locally Advanced Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Kano K; Yamada T; Komori K; Watanabe H; Takahashi K; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2021 Dec; 28(13):8464-8472. PubMed ID: 34114182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a survival difference between older adult and younger adult patients with locally advanced gastric cancer with the same lymph node ratio?
    Yalkin O; Iflazoglu N; Deniz O; Uzunoglu MY; Turhan EI
    J Geriatr Oncol; 2022 Sep; 13(7):962-969. PubMed ID: 35739052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
    Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
    J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
    BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
    Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
    Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
    Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
    Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Komori K; Tamagawa A; Nakazano M; Hara K; Hashimoto I; Tamagawa H; Segami K; Maezawa Y; Kano K; Oshima T; Yukawa N; Rino Y
    In Vivo; 2022; 36(2):994-1000. PubMed ID: 35241561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study.
    Wang Y; Xu H; Hu C; Yu P; Bao Z; Zhang Y; Zhang R; Zhang S; Li B; Aerts JM; Xu Z; Cheng X
    J Gastrointest Oncol; 2022 Jun; 13(3):1046-1057. PubMed ID: 35837180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the metastatic lymph node ratio compared to the TNM classification in stage III gastric cancer.
    Gulmez S; Senger AS; Uzun O; Omeroglu S; Ofluoglu C; Sert ZO; Oz A; Polat E; Duman M
    Niger J Clin Pract; 2021 Nov; 24(11):1602-1608. PubMed ID: 34782497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
    Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
    Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.
    Wang J; Liu F; Ma W; Hu H; Li F
    Langenbecks Arch Surg; 2023 Sep; 408(1):382. PubMed ID: 37770780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.